2022 | NOVEL-1st: an observational study to assess the safety and efficacy of nilotinib in newly diagnosed patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase in Taiwan | Hwang, Wen-Li; Chen, Tsung-Chih; Lin, Hsuan-Yu; Chang, Ming-Chih; Hsiao, Pei-Ching; Bai, Li-Yuan; Kuo, Ching-Yuan; Chen, Yeu-Chin; Liu, Ta-Chih; Gau, Jyh-Pyng; Wang, Po-Nan; Hwang, Wei-Shou; Kuo, Ming-Chung; Liu, Chun-Yu; Liu, Yi-Chang; Ma, Ming-Chun; Su, Nai-Wen; Wang, Chuan-Cheng; Wu, Yi-Ying; MING YAO ; Yeh, Su-Peng; Cheng, Hao-Wei; Lee, Yee-Ming; Ku, Fan-Chen; JIH-LUH TANG | International journal of hematology | 2 | 2 | |
2015 | Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trial | Platzbecker, Uwe; Wong, Raymond S M; Verma, Amit; Abboud, Camille; Araujo, Sergio; Chiou, Tzeon-Jye; Feigert, John; Yeh, Su-Peng; Götze, Katharina; Gorin, Norbert-Claude; Greenberg, Peter; Kambhampati, Suman; Kim, Yoo-Jin; Lee, Je-Hwan; Lyons, Roger; Ruggeri, Marco; Santini, Valeria; Cheng, Gregory; Jang, Jun Ho; Chen, Chien-Yuan ; Johnson, Brendan; Bennett, John; Mannino, Frank; Kamel, Yasser Mostafa; Stone, Nicole; Dougherty, Souria; Chan, Geoffrey; Giagounidis, Aristoteles | The Lancet. Haematology | 63 | 57 | |